Interesting UBS have started to follow the SRX story
"UBS believes Sirtex has a good chance of achieving positive trial results, based on medical literature and previously published results. It suggests that the elevation of SIR-Spheres to a first-line therapy could expand its addressable market sixfold."
http://www.theaustralian.com.au/business/companies/wongs-therapy-works-for-sirtex/story-fn91v9q3-1226296392239
If you put the above link in a google search (not the address bar) then click on the story you will be able to read the full story without having to sign up.
australian story on sirtex
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.24M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $109.3K | 836.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 365703 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 812922 | 5 |
View Market Depth
| Last trade - 15.53pm 28/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |